Cellectar Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details Textual)

STOCKHOLDERS' EQUITY (Details Textual) - USD ($)		1 Months Ended				9 Months Ended
STOCKHOLDERS' EQUITY (Details Textual) - USD ($)	Feb. 08, 2016	Nov. 29, 2016	Nov. 23, 2016	Apr. 20, 2016	Apr. 15, 2016	Sep. 30, 2017	Dec. 31, 2016	Apr. 13, 2016
Class of Warrant or Right [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						8,726,536
Common Stock, Shares Authorized	40,000,000					80,000,000	40,000,000
Stockholders' Equity, Reverse Stock Split	At a special meeting held on February 8, 2016, the Company’s stockholders approved an amendment to the Company’s certificate of incorporation to effect a reverse split of the Company’s common stock at a ratio between 1:5 to 1:10 in order to ensure that adequate authorized but unissued shares would be available for anticipated future financings, and to satisfy requirements for the continued listing of the Company’s common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue remained unchanged at 40,000,000. The Company’s stockholders further authorized the board of directors to determine the ratio at which the reverse split would be effected by filing an appropriate amendment to the Company’s certificate of incorporation. The board of directors authorized the ratio of the reverse split and corresponding reduction in authorized shares on February 24, 2016, and effective at the close of business on March 4, 2016, the Company’s certificate of incorporation was amended to effect a 1-for-10 reverse split of the Company’s common stock (the “2016 Reverse Split”). All share and per share numbers included in these consolidated financial statements give effect to the 2016 Reverse Split.
Series A Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Conversion of Stock, Shares Issued						1,133,339
Preferred Stock Shares Outstanding						0	17
Series B Pre-Funded Warrant [Member]
Class of Warrant or Right [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.01
Warrants Issued To Purchase Common Stock, Shares				1,908,021	1,908,021
Public Offering Price Per Share Of Shares And Warrants					$ 2.12
Series A Pre-Funded Warrant [Member]
Class of Warrant or Right [Line Items]
Class of Warrant or Right, Outstanding					3.04
Public Offering Price Per Share Of Shares And Warrants					$ 2.13
Series Z Convertible Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Warrants Issued To Purchase Common Stock, Shares					492,957
Series C Pre Funded Warrant [Member]
Class of Warrant or Right [Line Items]
Net Proceeds From Offering						$ 2,963,259
Warrants Issued To Purchase Common Stock, Shares						1,975,506
Underwritten Offering 2016 [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues				1,871,321
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 2.13
Stock Issued During Period, Value, New Issues				$ 8,000,000
Proceeds from Issuance Initial Public Offering				$ 7,200,000
Ladenburg Thalmann [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues					1,378,364
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 1.50
Warrants Issued To Purchase Common Stock, Shares			5,333,356
Public Offering Price Per Share Of Shares And Warrants			$ 100,000
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			66,667
Ladenburg Thalmann [Member] \| Series A Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues			68
Convertible Preferred Stock, Shares Issued upon Conversion			4,533,356
Number Of Securities Each Preferred Stock Converted			66,667
Public Offering Price Per Share Of Shares And Warrants			$ 1.50
Ladenburg Thalmann [Member] \| Underwritten Offering 2016 [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Value, New Issues		$ 9,200,000
Proceeds from Issuance Initial Public Offering		$ 8,300,000
Over-Allotment Option [Member] \| Series A Pre-Funded Warrant [Member]
Class of Warrant or Right [Line Items]
Conversion of Stock, Shares Issued					492,957
Over-Allotment Option [Member] \| Ladenburg Thalmann [Member]
Class of Warrant or Right [Line Items]
Warrants Issued To Purchase Common Stock, Shares			800,000
August 2014 Underwritten Offering [Member]
Class of Warrant or Right [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						9,704
Common Stock [Member] \| Ladenburg Thalmann [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues			800,000
Common Stock [Member] \| Over-Allotment Option [Member] \| Ladenburg Thalmann [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues			800,000
Series A Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants Issued To Purchase Common Stock, Shares					3,286,385
Warrants Issued To Purchase Common Stock, Shares				3,779,342
Series A Warrants [Member] \| Ladenburg Thalmann [Member]
Class of Warrant or Right [Line Items]
Public Offering Price Per Share Of Shares And Warrants			$ 1.50